Latest News about VIR
Recent news which mentions VIR
64 Biggest Movers From Friday
March 28, 2022
From Benzinga
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
March 25, 2022
From Motley Fool
From Benzinga
GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows
March 11, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 08, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 07, 2022
From Benzinga
From Motley Fool
From Benzinga
Where to Invest $10,000 in a Bear Market
March 02, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
From Motley Fool
From Benzinga
Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
February 08, 2022
From Benzinga
From Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
From MarketWatch
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
From MarketWatch
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
From MarketWatch
2 Best COVID-19 Growth Stocks to Own in 2022
January 17, 2022
From Motley Fool
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
From Motley Fool
GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
January 13, 2022
From Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.